EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis

Daisuke Kyuno, Hiroaki Shima, Yuka Mizue, Reona Okumura, Hinae Asano, Asaka Wada, Akira C Saito, Masayuki Koyama, Goro Kutomi, Yoshihiko Hirohashi, Takayuki Anazawa, Makoto Osanai

Surgery Today · 2026-11 · 56 (11) · 3010-3024

DOI: 10.1007/s00595-026-03454-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Surgery Today, online erschienen am 06.08.2026. Verfasst von Daisuke Kyuno und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-ku, Sapporo, 060-8556, Japan. kyuno@sapmed.ac.jp. Hauptthemen laut MEDLINE: Autoantibodies, Breast Neoplasms, HSP40 Heat-Shock Proteins, Biomarkers, Tumor. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Surgical Society, Northern Advancement Center for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: We evaluated the clinical significance of plasma autoantibodies against cancer stem cell-associated antigens in breast cancer, with diagnostic performance as the primary endpoint and clinicopathological and prognostic relevance as secondary endpoints. METHODS: In this single-center observational study, autoantibodies against SOX2, survivin, and DNAJB8 were measured using ELISA. The diagnostic performance of anti-DNAJB8 autoantibodies was evaluated in 292 patients with breast cancer and 24 benign controls. Clinicopathological and postoperative analyses were exploratory in a preoperative cohort (175 patients). RESULTS: Only DNAJB8 showed a distinct high-titer subset in the breast cancer group. The primary endpoint was not met, as plasma anti-DNAJB8 autoantibodies showed a non-significant diagnostic performance (AUC, 0.602; 95% CI, 0.488-0.715; P = 0.080). In the preoperative cohort, with six deaths and 11 recurrences, anti-DNAJB8 autoantibody positivity was associated with a worse overall and recurrence-free survival in age-adjusted analyses using Firth's penalized likelihood Cox regression (overall survival: hazard ratio, 10.607; 95% CI, 2.280-61.840; P = 0.003; recurrence-free survival: hazard ratio, 4.329; 95% CI, 1.247-13.082; P = 0.023). CONCLUSION: The primary diagnostic endpoint was not achieved for plasma anti-DNAJB8 autoantibodies. However, anti-DNAJB8 autoantibody positivity was associated with poorer postoperative outcomes, suggesting a hypothesis-generating prognostic relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesBreast NeoplasmsHSP40 Heat-Shock ProteinsBiomarkers, TumorMolecular ChaperonesHumansFemalePrognosisMiddle AgedPreoperative PeriodSurvivinSOXB1 Transcription FactorsInhibitor of Apoptosis ProteinsAgedPostoperative PeriodEnzyme-Linked Immunosorbent AssayAdult

Stichwörter der Autor:innen

AutoantibodyBreast cancerDNAJB8Prognosis

Substanzen

AutoantibodiesHSP40 Heat-Shock ProteinsBiomarkers, TumorSurvivinSOXB1 Transcription FactorsInhibitor of Apoptosis ProteinsBIRC5 protein, humanMolecular Chaperones

Autor:innen und Institutionen

  • Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-ku, Sapporo, 060-8556, Japan. kyuno@sapmed.ac.jp.
  • Department of Surgery, Division of Breast Surgery, Sapporo Medical University, Sapporo, Japan.
  • Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-ku, Sapporo, 060-8556, Japan.
  • Department of Applied Informatics, Center for Medical Education, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Social Medicine, Division of Public Health, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Surgical Society
  • Northern Advancement Center for Science and Technology

Zitieren

APA

Kyuno, D., Shima, H., Mizue, Y., Okumura, R., Asano, H., Wada, A., Saito, A. C., Koyama, M., Kutomi, G., Hirohashi, Y., Anazawa, T., & Osanai, M. (2026). Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis. Surgery Today, 56(11), 3010-3024. https://doi.org/10.1007/s00595-026-03454-2

Vancouver

Kyuno D, Shima H, Mizue Y, Okumura R, Asano H, Wada A, et al. Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis. Surgery Today. 2026;56(11):3010-3024. doi:10.1007/s00595-026-03454-2

BibTeX
@article{Kyuno2026,
  author = {Kyuno, Daisuke and Shima, Hiroaki and Mizue, Yuka and Okumura, Reona and Asano, Hinae and Wada, Asaka and Saito, Akira C and Koyama, Masayuki and Kutomi, Goro and Hirohashi, Yoshihiko and Anazawa, Takayuki and Osanai, Makoto},
  title = {Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {3010--3024},
  doi = {10.1007/s00595-026-03454-2}
}
Kostenlos starten →